APO Research
Talk to an analyst

APO RESEARCH · REPORT

Treatment of PNH

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Treatment of PNH Market Outlook and Growth Opportunities 2026

29 December 2025198 pages

Choose your research edition.

Industry ResearchTreatment of PNH Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Treatment of PNH Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Treatment of PNH Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treatment of PNH Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Treatment of PNH Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Treatment of PNH market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Treatment of PNH market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Treatment of PNH market include Alexion Pharmaceuticals, Apellis Pharmaceuticals, Samsung Bioepis, Amgen, Roche and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Treatment of PNH market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Treatment of PNH and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Treatment of PNH sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Treatment of PNH market size, projected growth trends, production technologies, key applications, and end-use industries.

Treatment of PNH Segment by Company

Alexion Pharmaceuticals

Apellis Pharmaceuticals

Samsung Bioepis

Amgen

Roche

Novartis

Treatment of PNH Segment by Type

Complement Inhibitors

Supportive Care

Others

Treatment of PNH Segment by Application

Hospital

Clinic

Other

Treatment of PNH Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Treatment of PNH status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Treatment of PNH market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Treatment of PNH significant trends, drivers, influence factors in global and regions.

6. To analyze Treatment of PNH competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment of PNH market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment of PNH and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment of PNH.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Treatment of PNH market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Treatment of PNH industry.

Chapter 3: Detailed analysis of Treatment of PNH manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Treatment of PNH in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Treatment of PNH in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Treatment of PNH Industry Trends Table 2. Treatment of PNH Industry Drivers Table 3. Treatment of PNH Industry Opportunities and Challenges Table 4. Treatment of PNH Industry Restraints Table 5. Global Treatment of PNH Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Treatment of PNH Revenue Share by Company (2021-2026) Table 7. Global Treatment of PNH Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Treatment of PNH Sales Volume Share by Company (2021-2026) Table 9. Global Treatment of PNH Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Treatment of PNH Company Ranking, (2024-2026) & (USD Million) Table 11. Global Treatment of PNH Key Company Manufacturing Base & Headquarters Table 12. Global Treatment of PNH Company, Product Type & Application Table 13. Global Treatment of PNH Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Treatment of PNH by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Complement Inhibitors Table 18. Significant Companies of Supportive Care Table 19. Significant Companies of Others Table 20. Global Treatment of PNH Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Treatment of PNH Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Treatment of PNH Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Treatment of PNH Sales Volume Share by Type (2021-2026) Table 24. Global Treatment of PNH Sales Volume Share by Type (2027-2032) Table 25. Global Treatment of PNH Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Treatment of PNH Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Treatment of PNH Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Treatment of PNH Sales Value Share by Type (2021-2026) Table 29. Global Treatment of PNH Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Treatment of PNH Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Treatment of PNH Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Treatment of PNH Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Treatment of PNH Sales Volume Share by Application (2021-2026) Table 37. Global Treatment of PNH Sales Volume Share by Application (2027-2032) Table 38. Global Treatment of PNH Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Treatment of PNH Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Treatment of PNH Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Treatment of PNH Sales Value Share by Application (2021-2026) Table 42. Global Treatment of PNH Sales Value Share by Application (2027-2032) Table 43. Global Treatment of PNH Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Treatment of PNH Sales by Region (2021-2026) & (K Units) Table 45. Global Treatment of PNH Sales Market Share by Region (2021-2026) Table 46. Global Treatment of PNH Sales by Region (2027-2032) & (K Units) Table 47. Global Treatment of PNH Sales Market Share by Region (2027-2032) Table 48. Global Treatment of PNH Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Treatment of PNH Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Treatment of PNH Sales Value Share by Region (2021-2026) Table 51. Global Treatment of PNH Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Treatment of PNH Sales Value Share by Region (2027-2032) Table 53. Global Treatment of PNH Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Treatment of PNH Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Treatment of PNH Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Treatment of PNH Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 58. Global Treatment of PNH Sales Market Share by Country (2021-2026) Table 59. Global Treatment of PNH Sales by Country (2027-2032) & (K Units) Table 60. Global Treatment of PNH Sales Market Share by Country (2027-2032) Table 61. Global Treatment of PNH Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Treatment of PNH Sales Value Market Share by Country (2021-2026) Table 63. Global Treatment of PNH Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Treatment of PNH Sales Value Market Share by Country (2027-2032) Table 65. Alexion Pharmaceuticals Company Information Table 66. Alexion Pharmaceuticals Business Overview Table 67. Alexion Pharmaceuticals Treatment of PNH Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Alexion Pharmaceuticals Treatment of PNH Product Portfolio Table 69. Alexion Pharmaceuticals Recent Development Table 70. Apellis Pharmaceuticals Company Information Table 71. Apellis Pharmaceuticals Business Overview Table 72. Apellis Pharmaceuticals Treatment of PNH Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Apellis Pharmaceuticals Treatment of PNH Product Portfolio Table 74. Apellis Pharmaceuticals Recent Development Table 75. Samsung Bioepis Company Information Table 76. Samsung Bioepis Business Overview Table 77. Samsung Bioepis Treatment of PNH Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Samsung Bioepis Treatment of PNH Product Portfolio Table 79. Samsung Bioepis Recent Development Table 80. Amgen Company Information Table 81. Amgen Business Overview Table 82. Amgen Treatment of PNH Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Amgen Treatment of PNH Product Portfolio Table 84. Amgen Recent Development Table 85. Roche Company Information Table 86. Roche Business Overview Table 87. Roche Treatment of PNH Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Roche Treatment of PNH Product Portfolio Table 89. Roche Recent Development Table 90. Novartis Company Information Table 91. Novartis Business Overview Table 92. Novartis Treatment of PNH Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Novartis Treatment of PNH Product Portfolio Table 94. Novartis Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Treatment of PNH Distributors List Table 98. Treatment of PNH Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Treatment of PNH Product Image Figure 2. Global Treatment of PNH Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment of PNH Sales Value (2021-2032) & (US$ Million) Figure 4. Global Treatment of PNH Sales (2021-2032) & (K Units) Figure 5. Global Treatment of PNH Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Treatment of PNH Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Complement Inhibitors Image Figure 10. Supportive Care Image Figure 11. Others Image Figure 12. Global Treatment of PNH Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Treatment of PNH Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Treatment of PNH Sales Volume Share by Type (2021-2032) Figure 15. Global Treatment of PNH Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Treatment of PNH Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Treatment of PNH Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Treatment of PNH Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Treatment of PNH Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Treatment of PNH Sales Volume Share by Application (2021-2032) Figure 24. Global Treatment of PNH Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Treatment of PNH Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Treatment of PNH Sales Value Share by Application (2021-2032) Figure 27. Global Treatment of PNH Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Treatment of PNH Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Treatment of PNH Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Treatment of PNH Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Treatment of PNH Sales Value (2021-2032) & (US$ Million) Figure 32. North America Treatment of PNH Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Treatment of PNH Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Treatment of PNH Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Treatment of PNH Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Treatment of PNH Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Treatment of PNH Sales Value (2021-2032) & (US$ Million) Figure 38. South America Treatment of PNH Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Treatment of PNH Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Treatment of PNH Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Treatment of PNH Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Treatment of PNH Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Treatment of PNH Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Treatment of PNH Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Treatment of PNH Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Complement Inhibitors
  • Supportive Care
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Alexion Pharmaceuticals
  • Apellis Pharmaceuticals
  • Samsung Bioepis
  • Amgen
  • Roche
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Treatment of PNH Sales Value (2021-2032)
  4. 1.2.2 Global Treatment of PNH Sales Volume (2021-2032)
  5. 1.2.3 Global Treatment of PNH Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Treatment of PNH Market Dynamics
  1. 2.1 Treatment of PNH Industry Trends
  2. 2.2 Treatment of PNH Industry Drivers
  3. 2.3 Treatment of PNH Industry Opportunities and Challenges
  4. 2.4 Treatment of PNH Industry Restraints
3 Treatment of PNH Market by Company
  1. 3.1 Global Treatment of PNH Company Revenue Ranking in 2025
  2. 3.2 Global Treatment of PNH Revenue by Company (2021-2026)
  3. 3.3 Global Treatment of PNH Sales Volume by Company (2021-2026)
  4. 3.4 Global Treatment of PNH Average Price by Company (2021-2026)
  5. 3.5 Global Treatment of PNH Company Ranking (2024-2026)
  6. 3.6 Global Treatment of PNH Company Manufacturing Base and Headquarters
  7. 3.7 Global Treatment of PNH Company Product Type and Application
  8. 3.8 Global Treatment of PNH Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Treatment of PNH Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Treatment of PNH Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Treatment of PNH Market by Type
  1. 4.1 Treatment of PNH Type Introduction
  2. 4.1.1 Complement Inhibitors
  3. 4.1.2 Supportive Care
  4. 4.1.3 Others
  5. 4.2 Global Treatment of PNH Sales Volume by Type
  6. 4.2.1 Global Treatment of PNH Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Treatment of PNH Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Treatment of PNH Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Treatment of PNH Sales Value by Type
  10. 4.3.1 Global Treatment of PNH Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Treatment of PNH Sales Value by Type (2021-2032)
  12. 4.3.3 Global Treatment of PNH Sales Value Share by Type (2021-2032)
5 Treatment of PNH Market by Application
  1. 5.1 Treatment of PNH Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Treatment of PNH Sales Volume by Application
  6. 5.2.1 Global Treatment of PNH Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Treatment of PNH Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Treatment of PNH Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Treatment of PNH Sales Value by Application
  10. 5.3.1 Global Treatment of PNH Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Treatment of PNH Sales Value by Application (2021-2032)
  12. 5.3.3 Global Treatment of PNH Sales Value Share by Application (2021-2032)
6 Treatment of PNH Regional Sales and Value Analysis
  1. 6.1 Global Treatment of PNH Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Treatment of PNH Sales by Region (2021-2032)
  3. 6.2.1 Global Treatment of PNH Sales by Region: 2021-2026
  4. 6.2.2 Global Treatment of PNH Sales by Region (2027-2032)
  5. 6.3 Global Treatment of PNH Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Treatment of PNH Sales Value by Region (2021-2032)
  7. 6.4.1 Global Treatment of PNH Sales Value by Region: 2021-2026
  8. 6.4.2 Global Treatment of PNH Sales Value by Region (2027-2032)
  9. 6.5 Global Treatment of PNH Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Treatment of PNH Sales Value (2021-2032)
  12. 6.6.2 North America Treatment of PNH Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Treatment of PNH Sales Value (2021-2032)
  15. 6.7.2 Europe Treatment of PNH Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Treatment of PNH Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Treatment of PNH Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Treatment of PNH Sales Value (2021-2032)
  21. 6.9.2 South America Treatment of PNH Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Treatment of PNH Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Treatment of PNH Sales Value Share by Country, 2025 VS 2032
7 Treatment of PNH Country-level Sales and Value Analysis
  1. 7.1 Global Treatment of PNH Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Treatment of PNH Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Treatment of PNH Sales by Country (2021-2032)
  4. 7.3.1 Global Treatment of PNH Sales by Country (2021-2026)
  5. 7.3.2 Global Treatment of PNH Sales by Country (2027-2032)
  6. 7.4 Global Treatment of PNH Sales Value by Country (2021-2032)
  7. 7.4.1 Global Treatment of PNH Sales Value by Country (2021-2026)
  8. 7.4.2 Global Treatment of PNH Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Treatment of PNH Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Treatment of PNH Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Treatment of PNH Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Treatment of PNH Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Treatment of PNH Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Treatment of PNH Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Treatment of PNH Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Treatment of PNH Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Treatment of PNH Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Treatment of PNH Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Treatment of PNH Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Treatment of PNH Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Treatment of PNH Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Treatment of PNH Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Treatment of PNH Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Treatment of PNH Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Treatment of PNH Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Treatment of PNH Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Treatment of PNH Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Treatment of PNH Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Treatment of PNH Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Treatment of PNH Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Treatment of PNH Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Treatment of PNH Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Treatment of PNH Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Treatment of PNH Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Treatment of PNH Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Treatment of PNH Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Treatment of PNH Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Treatment of PNH Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Treatment of PNH Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alexion Pharmaceuticals
  2. 8.1.1 Alexion Pharmaceuticals Company Information
  3. 8.1.2 Alexion Pharmaceuticals Business Overview
  4. 8.1.3 Alexion Pharmaceuticals Treatment of PNH Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alexion Pharmaceuticals Treatment of PNH Product Portfolio
  6. 8.1.5 Alexion Pharmaceuticals Recent Developments
  7. 8.2 Apellis Pharmaceuticals
  8. 8.2.1 Apellis Pharmaceuticals Company Information
  9. 8.2.2 Apellis Pharmaceuticals Business Overview
  10. 8.2.3 Apellis Pharmaceuticals Treatment of PNH Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Apellis Pharmaceuticals Treatment of PNH Product Portfolio
  12. 8.2.5 Apellis Pharmaceuticals Recent Developments
  13. 8.3 Samsung Bioepis
  14. 8.3.1 Samsung Bioepis Company Information
  15. 8.3.2 Samsung Bioepis Business Overview
  16. 8.3.3 Samsung Bioepis Treatment of PNH Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Samsung Bioepis Treatment of PNH Product Portfolio
  18. 8.3.5 Samsung Bioepis Recent Developments
  19. 8.4 Amgen
  20. 8.4.1 Amgen Company Information
  21. 8.4.2 Amgen Business Overview
  22. 8.4.3 Amgen Treatment of PNH Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Treatment of PNH Product Portfolio
  24. 8.4.5 Amgen Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Treatment of PNH Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Roche Treatment of PNH Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Treatment of PNH Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Treatment of PNH Product Portfolio
  36. 8.6.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Treatment of PNH Value Chain Analysis
  2. 9.1.1 Treatment of PNH Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Treatment of PNH Sales Mode & Process
  6. 9.2 Treatment of PNH Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Treatment of PNH Distributors
  9. 9.2.3 Treatment of PNH Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst